Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland China.
Ann Gen Psychiatry
; 22(1): 37, 2023 Oct 06.
Article
in En
| MEDLINE
| ID: mdl-37803378
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Risk_factors_studies
/
Screening_studies
Language:
En
Journal:
Ann Gen Psychiatry
Year:
2023
Type:
Article
Affiliation country:
China